Think twice, ask once: reducing preventable waste in theatre QP Case Study January 2017
Antibiotics for acute laryngitis in adults Cochrane Topic January 2017 Exclude
Ursodeoxycholic acid for cystic fibrosis-related liver disease Cochrane Topic January 2017 Very Low
Inhaled corticosteroids for cystic fibrosis Cochrane Topic January 2017 Very Low
KTT19: Psychotropic medicines in people with learning disabilities whose behaviour challenges Key Therapeutic Topic January 2017 Unclassified
KTT21: Medicines optimisation in long-term pain Key Therapeutic Topic January 2017 Unclassified
KTT18: Multimorbidity and polypharmacy Key Therapeutic Topic January 2017 Unclassified
KTT20: Safer insulin prescribing Key Therapeutic Topic January 2017 Unclassified
Do not offer nicotinic acid (niacin) for the prevention of CVD to any of the following: people who are being treated for primary prevention, people who are being treated for secondary prevention, people with CKD, people with type 1 diabetes, people with type 2 diabetes. Do not do recommendation December 2016
Do not delay statin treatment in secondary prevention to manage modifiable risk factors. Do not do recommendation December 2016